Shelby Corman

1.7k total citations
81 papers, 1.2k citations indexed

About

Shelby Corman is a scholar working on Surgery, Oncology and Epidemiology. According to data from OpenAlex, Shelby Corman has authored 81 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 15 papers in Oncology and 15 papers in Epidemiology. Recurrent topics in Shelby Corman's work include Economic and Financial Impacts of Cancer (10 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Anesthesia and Pain Management (7 papers). Shelby Corman is often cited by papers focused on Economic and Financial Impacts of Cancer (10 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Anesthesia and Pain Management (7 papers). Shelby Corman collaborates with scholars based in United States, Germany and United Kingdom. Shelby Corman's co-authors include Nishant R. Shah, Girish P. Joshi, Jeff Gadsden, Kishor Gandhi, Susan J. Skledar, Colleen M. Culley, Caitlyn T. Solem, Jennifer Stephens, Stacey M. Lavsa and Claudie Charbonneau and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Shelby Corman

78 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shelby Corman United States 17 364 247 120 108 102 81 1.2k
M G Coulthard Australia 26 338 0.9× 378 1.5× 120 1.0× 94 0.9× 37 0.4× 81 2.0k
Robin J. Larson United States 20 425 1.2× 589 2.4× 83 0.7× 159 1.5× 98 1.0× 29 2.2k
Belchin Kostov Spain 26 290 0.8× 253 1.0× 136 1.1× 125 1.2× 113 1.1× 77 1.9k
Antonio Vallano Spain 22 128 0.4× 181 0.7× 48 0.4× 95 0.9× 51 0.5× 89 1.7k
Antoni Sisó‐Almirall Spain 30 471 1.3× 263 1.1× 200 1.7× 205 1.9× 224 2.2× 113 2.7k
Joseph Mattana United States 24 304 0.8× 206 0.8× 113 0.9× 38 0.4× 82 0.8× 111 1.8k
G. Morelli Italy 24 600 1.6× 417 1.7× 56 0.5× 143 1.3× 88 0.9× 107 1.7k
Ying‐Huang Tsai Taiwan 29 298 0.8× 415 1.7× 135 1.1× 282 2.6× 62 0.6× 85 2.3k
Adam S. Cifu United States 21 236 0.6× 175 0.7× 82 0.7× 140 1.3× 58 0.6× 99 1.6k
Antonella Delmestri United Kingdom 21 623 1.7× 234 0.9× 290 2.4× 231 2.1× 37 0.4× 111 1.6k

Countries citing papers authored by Shelby Corman

Since Specialization
Citations

This map shows the geographic impact of Shelby Corman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shelby Corman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shelby Corman more than expected).

Fields of papers citing papers by Shelby Corman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shelby Corman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shelby Corman. The network helps show where Shelby Corman may publish in the future.

Co-authorship network of co-authors of Shelby Corman

This figure shows the co-authorship network connecting the top 25 collaborators of Shelby Corman. A scholar is included among the top collaborators of Shelby Corman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shelby Corman. Shelby Corman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dagenais, Simon, Zaher A. Radi, Griffith Bell, et al.. (2024). Comparing five equations to estimate glomerular filtration rate or creatinine clearance and assign individuals to KDIGO categories across the full age spectrum using real world data. Clinical and Translational Science. 17(2). 1 indexed citations
2.
Girardi, Michael, Kacie R. Carlson, Xingyue Huang, et al.. (2024). Chart review study of real-world clinical outcomes in patients with cutaneous T-cell lymphoma treated with extracorporeal photopheresis in the US in 2017–2019. Journal of Dermatological Treatment. 35(1). 2360568–2360568. 2 indexed citations
3.
Shah, Ruchit, et al.. (2023). The burden of ovarian cancer in the USA from 2007 to 2018: evidence from the Medical Expenditure Panel Survey. Future Oncology. 19(19). 1331–1342. 2 indexed citations
4.
Zeidan, Amer M., Namita Joshi, Hrishikesh Kale, et al.. (2022). Impact of Hypomethylating Agent Use on Hospital and Emergency Room Visits, and Predictors of Early Discontinuation in Patients With Higher-Risk Myelodysplastic Syndromes. Clinical Lymphoma Myeloma & Leukemia. 22(9). 670–679. 4 indexed citations
5.
Abman, Steven H., Mehreen Malik, Sneha S. Kelkar, et al.. (2022). Real-world use of inhaled nitric oxide therapy in patients with COVID-19 and mild-to-moderate acute respiratory distress syndrome. Drugs in Context. 11. 1–9. 3 indexed citations
6.
Jiang, Shan, Della Varghese, Shelby Corman, et al.. (2021). Frequency, management, and resource use of adverse events (AEs) in nonmetastatic castrate-resistant prostate cancer (nmCRPC) patients receiving apalutamide or enzalutamide: A real-world study.. Journal of Clinical Oncology. 39(6_suppl). 217–217. 1 indexed citations
7.
Moore, Kevin, Khurram Jamil, Linlin Luo, et al.. (2020). Real‐world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome. Alimentary Pharmacology & Therapeutics. 52(2). 351–358. 23 indexed citations
8.
Shah, Ruchit, Chizoba Nwankwo, Young‐Min Kwon, & Shelby Corman. (2020). Economic and Humanistic Burden of Cervical Cancer in the United States: Results from a Nationally Representative Survey. Journal of Women s Health. 29(6). 799–805. 20 indexed citations
9.
Mohty, Mohamad, Wolfgang Knauf, Dorothy Romanus, et al.. (2020). Real‐world treatment patterns and outcomes in non‐transplant newly diagnosed multiple Myeloma in France, Germany, Italy, and the United Kingdom. European Journal Of Haematology. 105(3). 308–325. 10 indexed citations
10.
Patel, Anisha M., Shelby Corman, Stephen Chaplin, Karina Raimundo, & Robert F. Sidonio. (2019). Economic impact model of delayed inhibitor development in patients with hemophilia a receiving emicizumab for the prevention of bleeding events. Journal of Medical Economics. 22(12). 1328–1337. 13 indexed citations
11.
Shah, Ruchit, et al.. (2018). Economic and humanistic burden of cervical cancer in the United States. Annals of Oncology. 29. viii350–viii350. 2 indexed citations
12.
Corman, Shelby, Nishant R. Shah, & Simon Dagenais. (2017). Medication, equipment, and supply costs for common interventions providing extended post-surgical analgesia following total knee arthroplasty in US hospitals. Journal of Medical Economics. 21(1). 11–18. 10 indexed citations
13.
Moghnieh, Rima, Adel Alothman, Abdulhakeem Althaqafi, et al.. (2017). Epidemiology and outcome of invasive fungal infections and methicillin-resistant Staphylococcus aureus (MRSA) pneumonia and complicated skin and soft tissue infections (cSSTI) in Lebanon and Saudi Arabia. Journal of Infection and Public Health. 10(6). 849–854. 15 indexed citations
14.
Bröckelmann, Paul J., Erin Zagadailov, Shelby Corman, et al.. (2016). Brentuximab vedotin in patients who are ineligible for autologous stem cell transplant with relapsed or refractory Hodgkin lymphoma: a United Kingdom and Germany retrospective study.. Haematologica. 1 indexed citations
15.
Zagadailov, Erin, Shelby Corman, Michael P. Hagan, et al.. (2016). Real-world effectiveness of brentuximab vedotin vs other treatments in patients with relapsed/refractory Hodgkin lymphoma post autologous stem-cell transplantation.. Haematologica. 101. 51–51. 5 indexed citations
16.
Joshi, Girish P., Kishor Gandhi, Nishant R. Shah, Jeff Gadsden, & Shelby Corman. (2016). Peripheral nerve blocks in the management of postoperative pain: challenges and opportunities. Journal of Clinical Anesthesia. 35. 524–529. 182 indexed citations
17.
Copher, Ronda, et al.. (2015). Indirect Costs Among Metastatic Breast Cancer Patients Receiving Eribulin. Value in Health. 18(3). A202–A202. 1 indexed citations
18.
Lawson, W., Dilip Nathwani, Christian Eckmann, et al.. (2015). Weight-based antibiotic dosing in a real-world European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus. Clinical Microbiology and Infection. 21. S40–S46. 6 indexed citations
19.
Miller, Luke E., et al.. (2014). The role of clinical decision support in pharmacist response to drug-interaction alerts. Research in Social and Administrative Pharmacy. 11(3). 480–486. 8 indexed citations
20.
Schonder, Kristine S., et al.. (2010). Early Risk Factors for Persistent Anemia After Kidney Transplantation. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 30(12). 1214–1220. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026